A study to evaluate the efficacy of Triphaladi Kwath in management of Prameha

A clinical study to evaluate the efficacy of Triphaladi Kwath in the management of prameha w.s.r. to diabetes mellitus type-2 - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080886

Enrollment

Registered

2025-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject of age group between 20 and 60 years and irrespective of caste, sex, religion, occupation, and socio-economic status. 2. Subject with classical signs and symptoms will be included. 3. Disease chronicity less than 5 years 4. Non Insulin Dependent Diabetes Mellitus 5. Subject willing to give informed consent to participate for 60 days.

Exclusion criteria

Exclusion criteria: 1. Patients below 20 and above 60 years of age 2. Patients suffering from other systemic disorders like renal or cardiac disorders 3. Sahaja and Jataja Madhumeha, i.e. DM Type 1 patients 4. Patient on insulin therapy 5. Pregnant and lactating womens 6. Patients with diabetic gangrene carbuncles and other complications of diabetes like diabetic nephropathy and diabetic retinopathy 7. Diabetic ketoacidosis

Design outcomes

Primary

Measure	Time frame
Reduction in sign and symptoms of PramehaTimepoint: 75 days	—

Secondary

Measure	Time frame
Cost effective treatment and to observe if there are any adverse effectTimepoint: 75 days	—

Countries

India

Contacts

Public ContactDr AP Singh

Kunwar Shekhar Vijender Ayurved Medical College & Research Center

apsingh11264@gmail.com9410088322

Outcome results